Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Demecolcine results in increased expression of MT1HL1 mRNA | CTD | PMID:23649840 | 17beta-estradiol | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Estradiol results in increased expression of MT1HL1 mRNA | CTD | PMID:19619570 | 17beta-estradiol | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MT1HL1 mRNA | CTD | PMID:19619570 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of MT1HL1 mRNA | CTD | PMID:19619570 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MT1HL1 mRNA | CTD | PMID:19619570 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:26705709 | aflatoxin B1 | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of MT1HL1 mRNA | CTD | PMID:22100608 | antirheumatic drug | decreases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of MT1HL1 mRNA | CTD | PMID:24449571 | arsenous acid | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of MT1HL1 mRNA | CTD | PMID:15725085 and PMID:26705709 | avobenzone | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | avobenzone results in increased expression of MT1HL1 mRNA | CTD | PMID:31016361 | bis(2-ethylhexyl) phthalate | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of MT1HL1 mRNA | CTD | PMID:28412506 | cadmium atom | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MT1HL1 mRNA | CTD | PMID:31738976 | cadmium atom | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Cadmium results in increased expression of MT1HL1 mRNA | CTD | PMID:24376830 | cadmium dichloride | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of MT1HL1 mRNA | CTD | PMID:26314618 | cadmium dichloride | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MT1HL1 mRNA | CTD | PMID:31738976 | copper atom | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of MT1HL1 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of MT1HL1 mRNA | CTD | PMID:20971185 | diarsenic trioxide | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of MT1HL1 mRNA | CTD | PMID:15725085 and PMID:26705709 | dorsomorphin | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | entinostat results in increased expression of MT1HL1 mRNA | CTD | PMID:27188386 | lead diacetate | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | lead acetate results in increased expression of MT1HL1 mRNA | CTD | PMID:22839698 | mercury dibromide | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of MT1HL1 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1HL1 mRNA | CTD | PMID:27188386 | methylmercury chloride | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of MT1HL1 mRNA | CTD | PMID:28001369 | motexafin gadolinium | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of MT1HL1 mRNA] | CTD | PMID:16357179 | motexafin gadolinium | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | motexafin gadolinium results in increased expression of MT1HL1 mRNA | CTD | PMID:15867382 and PMID:16357179 | nickel atom | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Nickel results in increased expression of MT1HL1 mRNA | CTD | PMID:24768652 and PMID:25583101 | p-chloromercuribenzoic acid | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1HL1 mRNA | CTD | PMID:27188386 | p-chloromercuribenzoic acid | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of MT1HL1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1HL1 mRNA | CTD | PMID:27188386 | phenylmercury acetate | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of MT1HL1 mRNA | CTD | PMID:26272509 | SB 431542 | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | valproic acid | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MT1HL1 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MT1HL1 mRNA | CTD | PMID:23179753 more ... | vincristine | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Vincristine results in increased expression of MT1HL1 mRNA | CTD | PMID:23649840 | zinc acetate | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Zinc Acetate results in increased expression of MT1HL1 mRNA | CTD | PMID:16357179 | zinc acetate | multiple interactions | ISO | MT1HL1 (Homo sapiens) | 6480464 | motexafin gadolinium promotes the reaction [Zinc Acetate results in increased expression of MT1HL1 mRNA] | CTD | PMID:16357179 | zinc atom | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Zinc results in increased expression of MT1HL1 mRNA | CTD | PMID:16870260 | zinc dichloride | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | zinc chloride results in increased expression of MT1HL1 mRNA | CTD | PMID:16870260 | zinc(0) | increases expression | ISO | MT1HL1 (Homo sapiens) | 6480464 | Zinc results in increased expression of MT1HL1 mRNA | CTD | PMID:16870260 | |